oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Clinical pharmacist perspectives for optimizing pharmacotherapy within Enhanced Recovery After Surgery (ERAS (R)) programs
Mayo Clin, Rochester MN, USA.
Grant Medical Center, Columbus OH, USA.
Creighton University School of Pharmacy and Health Professions, Omaha NE, USA.
Departments of Obstetrics & Gynecology and Oncology, Section Chief, Gynecologic Oncology, Secretary, ERAS® Society, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary Alberta, Canada.
Show others and affiliations
2019 (English)In: International Journal of Surgery, ISSN 1743-9191, E-ISSN 1743-9159, Vol. 63, p. 58-62Article, review/survey (Refereed) Published
Abstract [en]

One of the most durable approaches to perioperative enhanced recovery programming has culminated in the formation of perioperative organizations devoted to improvements in the quality of the surgical patient experience, such as the Enhanced Recovery After Surgery (ERAS (R)) Society. Members of the American College of Clinical Pharmacy (ACCP) Perioperative Care Practice and Research Network (PRN) and officials from the ERAS (R) Society present an opinion that: (1) identifies therapeutic options within each pharmacotherapy-intensive area of ERAS (R); (2) generates applied research questions that would allow for comparative analyses of pharmacotherapy options within ERAS (R) programs; (3) proposes collaborative practice opportunities between key stakeholders in the surgical journey and clinical pharmacists to manage drug therapy problems and research questions; and (4) highlights examples of pharmacist-led cost savings attributed to ERAS (R) implementation. Clinical pharmacists, working in this manner with the perioperative team across the care continuum, have optimized pharmacotherapy towards measurable outcomes improvements, and stand ready to partner with inter-professional stakeholders and organizations to advance the care of our mutual patients.

Place, publisher, year, edition, pages
Elsevier, 2019. Vol. 63, p. 58-62
National Category
Surgery
Identifiers
URN: urn:nbn:se:oru:diva-73499DOI: 10.1016/j.ijsu.2019.01.006ISI: 000461663800007PubMedID: 30665004Scopus ID: 2-s2.0-85061611907OAI: oai:DiVA.org:oru-73499DiVA, id: diva2:1302317
Available from: 2019-04-04 Created: 2019-04-04 Last updated: 2019-04-04Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records BETA

Ljungqvist, Olle

Search in DiVA

By author/editor
Ljungqvist, Olle
By organisation
School of Medical Sciences
In the same journal
International Journal of Surgery
Surgery

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 55 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf